HC Deb 08 January 2002 vol 377 cc767-8W
Mr. Luff

To ask the Secretary of State for Environment, Food and Rural Affairs what timetable for the replacement of the currently marketed antibiotic feed additives containing mycelial grade substances with premixes containing pharmacopoeia grade active substances was agreed at the Veterinary Products Committee meeting of 18 October; and if she will make a statement. [22960]

Mr. Morley

[holding answer 19 December 2001]At its meeting of 18 October the Veterinary Products Committee agreed the following timetable for the replacement of mycelial grade antibiotics with pharmacopoeia antibiotics:

  • by 1 December 2003—marketing authorisation holders to submit to the Veterinary Medicines Directorate (VMD) valid applications for new marketing authorisations or to vary existing marketing authorisations;
  • by 1 December 2004—VMD to complete assessment of the relevant applications;
  • by 1 June 2005—marketing authorisation holders to implement the change.

Number of confirmed cases of BSE, by year of confirmation for each county in Great Britain 1990–14 December 2001
County 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001
Avon 257 474 643 607 391 285 210 106 52 40 22 10
Bedfordshire 37 67 93 96 78 45 22 13 11 3 2 2
Berkshire 58 104 178 157 126 107 54 54 22 19 9 6
Borders 19 54 100 154 101 51 25 3 10 2 3 2
Buckinghamshire 128 180 254 332 280 122 94 57 27 45 17 19
Cambridge 49 63 91 133 91 54 33 20 18 13 8 2
Central 9 17 37 67 54 23 5 6 3 1 1 2
Cheshire 366 903 1,519 1,560 1,144 694 339 184 110 89 34 29
Cleveland 21 23 42 58 36 30 20 15 9 5 9 4
Clwyd 132 353 534 623 439 261 117 81 48 58 21 15
Cornwall 834 1,679 2,458 2,124 1,181 688 387 194 130 123 81 45
Cumbria 237 595 1,153 1,328 910 534 344 182 111 75 40 21
Derbyshire 202 386 880 940 733 486 263 103 75 69 28 13
Devon 1,208 2,306 3,253 2,906 1,870 1,055 640 397 268 204 98 65
Dorset 1,048 1,655 2,061 1,824 1,199 725 423 271 206 136 66 37
Dumfries 85 203 518 671 463 233 112 49 27 16 9 13
Durham 54 71 164 171 159 117 60 40 23 13 10 4
Dyfed 550 1,145 1,863 1,905 1,214 655 293 131 94 49 36 25

Failure to meet this timetable could lead to the revocation of marketing authorisations.